California Business News - Page 66

Page 66 of California Business News issued by the Send2Press® Newswire service.



OnlineBootyCall Announces Cyberdating’s First-Ever Virtual Bikini Contest for Would Be Calendar Girls

SAN DIEGO, Calif. – June 3 (SEND2PRESS NEWSWIRE) — OnlineBootyCall.com, a division of Mobeze, Inc., today announced that it will become the first online dating destination to hold a virtual bikini contest on their site. A panel of OBC judges will review each contestant who registers for the OBC Bikini Calendar contest, and then choose a pool of initial finalists, from which OnlineBootyCall.com members will choose the hottest twelve contestants to adorn the pages of OnLineBootyCall’s 2006 Bikini Calendar.

Women’s JuJitsu Champion Revolutionizes Sport – Auctions Advertising Space on Rear of Brazilian Beauty’s Shorts

LONG BEACH, Calif. — (SEND2PRESS NEWSWIRE) — Internet casino GoldenPalace.com scored prime exposure with their latest eBay purchase, by winning a $2,225 auction for advertising space on the rear of Brazilian JuJitsu champion Gazzy Parman’s shorts for her historic competition in an elite submission grappling tournament that has never before included women.

Rexin-G, the World’s First Tumor-Targeted Gene Delivery Vector Used in Phase I Clinical Trial

LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corp. announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer.

Phase I Clinical Trial for Advanced Colon and Pancreatic Cancer Opens in New York Using Rexin-G, the World’s First Tumor-Targeted Gene Delivery Vector

LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation (www.epeiusbiotech.com) announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer. In 2003, Rexin-G gained FDA approval as an Orphan Drug based on clinical demonstrations of the medical utility of Rexin-G as an effective treatment for pancreatic cancer.

Non-Profit Organizations to Receive $22K in Free PR Grants and Marketing Support

LOS ANGELES, Calif. /Send2Press Newswire/ — Neotrope(R), a brand identity and marketing firm established Jan. 1983, is donating $22K in free public relations and newswire services to worthy non-profit and charitable organizations to celebrate its 22nd anniversary. Neotrope previously donated $25K worth of services in 2000, and has provided discounted or free services to various non-profits for more than 20 years. Organizations may apply for this program starting Jan 28.

100 Computers In 100 Days Will Be Refurbished For Reuse And Used By Community Nonprofits And Public School Teachers Around The Bay Area

SAN FRANCISCO, CA /Send2Press Newswire/ — Computers and Laptops donated this holiday season to Computer Recycling Center’s (C.R.C.) End-Of-the-Year Drop-Off event will go to the ‘Hundred for One-Hundred’ project. 100 computers in 100 days will be refurbished for reuse and used by community nonprofits and public school teachers around the Bay Area. C.R.C. is a 501-c-3 nonprofit organization.